0000103623-24-000011.txt : 20240119 0000103623-24-000011.hdr.sgml : 20240119 20240119163658 ACCESSION NUMBER: 0000103623-24-000011 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 24546094 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Rouan Sarah Kathryn CENTRAL INDEX KEY: 0001761366 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 144 1 primary_doc.xml 144 0001761366 XXXXXXXX LIVE 0001607678 Viking Therapeutics, Inc. 001-37355 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660 Rouan Sarah Kathryn Director common Oppenheimer & Co Inc

85 Broad Street New York NY 10004

30000 691500.00 100028953 01/19/2024 NASDAQ Common 07/01/2019 NQSO Issuer N 30000 01/19/2024 N/A Y POA on file - shares being sold pursuant to 10b5-1 trading plan dated 5/3/2023 01/19/2024 05/03/2023 Sarah Kathryn Rouan